, Nature, vol.557, p.279, 2018.

A. G. Administration and H. T. , Therapeutic Goods Administration (TGA). Text. Consulté 10 septembre, 2017.

A. , M. R. Et-w.-r, and . Lin, Regenerative medicine: Hepatic progenitor cells up their game in the therapeutic stakes, Nature Reviews. Gastroenterology & Hepatology, vol.12, pp.610-611, 2015.

P. W. Andrews, M. M. Matin, A. R. Bahrami, I. Damjanov, P. Gokhale et al., Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin, Biochemical Society Transactions, vol.33, pp.1526-1530, 2005.

O. Argyros, S. Wong, and R. P. Harbottle, Non-viral episomal modification of cells using S/MAR elements, Expert Opinion on Biological Therapy, vol.11, pp.1177-1191, 2011.

J. A. Aronowitz, R. A. Lockhart, and C. S. Hakakian, Mechanical versus enzymatic isolation of stromal vascular fraction cells from adipose tissue, 2015.

, Arrêté du 27 avril 2006 fixant la liste des informations transmises par l'Agence française de sécurité sanitaire des produits de santé à l'organisme gestionnaire de la base de données européenne des essais cliniques de médicaments à usage humain | Legifrance. (s. d.). Consulté 12 septembre, 2018.

, Australian regulatory guidelines for biologicals, Part 1-Introduction to the Australian regulatory guidelines for biologicals, p.44, 2011.

A. M. Bailey, J. Arcidiacono, K. A. Benton, Z. Taraporewala, and E. S. Winitsky, United States Food and Drug Administration Regulation of Gene and Cell Therapies, Advances in Experimental Medicine and Biology, vol.871, pp.1-29, 2015.

J. S. Bartlett, J. Kleinschmidt, R. C. Boucher, and R. J. Samulski, Targeted adenoassociated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody, Nature Biotechnology, vol.17, pp.181-186, 1999.

C. Y. Bayan, A. T. Lopez, R. D. Gartrell, K. M. Komatsubara, M. Bogardus et al., The Role of Oncolytic Viruses in the Treatment of Melanoma, Current Oncology Reports, vol.20, p.80, 2018.

E. Beutler, The Cline affair, Molecular Therapy: The Journal of the American Society of Gene Therapy, vol.4, pp.396-397, 2001.

R. M. Blaese, K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher et al., T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years, Science, vol.270, pp.475-480, 1995.

C. Bordignon, L. D. Notarangelo, N. Nobili, G. Ferrari, G. Casorati et al., Gene therapy in peripheral blood lymphocytes and bone marrow for ADAimmunodeficient patients, Science, vol.270, pp.470-475, 1995.

O. Boyer, V. Bridoux, C. Giverne, A. Bisson, E. Koning et al., , 2018.

, Autologous Myoblasts for the Treatment of Fecal Incontinence: Results of a Phase 2 Randomized Placebo-controlled Study (MIAS), Annals of Surgery, vol.267, pp.443-450

L. S. Branch, Consolidated federal laws of canada, Safety of Human Cells, Tissues and Organs for Transplantation Regulations. Consulté 12 septembre, 2015.

C. J. Buchholz, K. W. Peng, F. J. Morling, J. Zhang, F. L. Cosset et al., In vivo selection of protease cleavage sites from retrovirus display libraries, Nature Biotechnology, vol.16, pp.951-954, 1998.

V. Budker, G. Zhang, S. Knechtle, and J. A. Wolff, Naked DNA delivered intraportally expresses efficiently in hepatocytes, Gene Therapy, vol.3, pp.593-598, 1996.

B. Burgess-beusse, C. Farrell, M. Gaszner, M. Litt, V. Mutskov et al., The insulation of genes from external enhancers and silencing chromatin, Proceedings of the National Academy of Sciences of the United States of America 99 Suppl, vol.4, pp.16433-16437, 2002.

J. C. Burns, T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee, Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells, Proceedings of the National Academy of Sciences of the United States of America, vol.90, pp.8033-8037, 1993.
DOI : 10.1073/pnas.90.17.8033

URL : http://www.pnas.org/content/90/17/8033.full.pdf

E. Cambria, F. S. Pasqualini, P. Wolint, J. Günter, J. Steiger et al., Translational cardiac stem cell therapy: advancing from first-generation to nextgeneration cell types, NPJ Regenerative Medicine, vol.2, p.17, 2017.
DOI : 10.1038/s41536-017-0024-1

URL : https://www.nature.com/articles/s41536-017-0024-1.pdf

, CFR-Code of Federal Regulations Title 21. (s. d.-a), Consulté 16 août, 2018.

, CFR-Code of Federal Regulations Title 21. (s. d.-b). Consulté 11 septembre, 2018.

C. Chen, K. Wang, Q. Wang, and E. X. Wang, LncRNA HULC mediates radioresistance via autophagy in prostate cancer cells, Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas, vol.51, p.7080, 2018.

M. Choi, E. Han, S. Lee, T. Kim, and E. W. Shin, Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea, Advances in Experimental Medicine and Biology, vol.871, pp.163-179, 2015.

A. Ciccia and S. J. Elledge, The DNA damage response: making it safe to play with knives, Molecular Cell, vol.40, pp.179-204, 2010.

M. J. Cline, Perspectives for gene therapy: inserting new genetic information into mammalian cells by physical techniques and viral vectors, Pharmacology & Therapeutics, vol.29, pp.69-92, 1985.

, Proposition pour un règlement du parlement européen et du conseil sur les essais cliniques de produits de santé à usage humain et remplaçant la directive 2001/20/CE. Bruxelle, Commission européenne. (s. d.). Consulté 15 août, 2012.

N. H. Council and M. R. , National Approach to Single Ethical Review of Multi-Centre Research | National Health and Medical Research Council. Consulté 10 septembre, 2009.

A. M. Darquet, B. Cameron, P. Wils, D. Scherman, and J. Crouzet, A new DNA vehicle for nonviral gene delivery: supercoiled minicircle, Gene Therapy, vol.4, pp.1341-1349, 1997.

D. Dickson, NIH censure for Dr Martin Cline: tighter rules for future research plans, Nature, vol.291, p.369, 1981.

, Directive 2001/20/CE du Parlement européen et du Conseil du 4 avril 2001 concernant le rapprochement des dispositions législatives, réglementaires et administratives des États membres relatives à l'application de bonnes pratiques cliniques dans la conduite d'essais cliniques de médicaments à usage humain

, du 25 juin 2003, modifiant la directive 2001/83/CE du Parlement européen et du Conseil instituant un code communautaire relatif aux médicaments à usage humain, Directive 2003/63/CE de la Commission, 2003.

D. ,

B. Dong, H. Nakai, and W. Xiao, Characterization of genome integrity for oversized recombinant AAV vector, Molecular Therapy: The Journal of the American Society of Gene Therapy, vol.18, pp.87-92, 2010.

D. Duan, Y. Yue, Z. Yan, and J. F. Engelhardt, A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation, Nature Medicine, vol.6, pp.595-598, 2000.

C. E. Dunbar, K. A. High, J. K. Joung, D. B. Kohn, K. Ozawa et al., Gene therapy comes of age, p.359, 2018.

A. Elsanhoury, R. Sanzenbacher, P. Reinke, and M. Abou-el-enein, Accelerating Patients' Access to Advanced Therapies in the EU, Molecular Therapy. Methods & Clinical Development, vol.7, pp.15-19, 2017.

J. D. Elster, D. K. Krishnadas, and K. G. Lucas, Dendritic cell vaccines: A review of recent developments and their potential pediatric application, Human Vaccines & Immunotherapeutics, vol.12, pp.2232-2239, 2016.

S. E. Fischer, RNA Interference and MicroRNA-Mediated Silencing, Current Protocols in Molecular Biology, vol.112, pp.26-27, 2015.
DOI : 10.1002/0471142727.mb2601s112

T. Friedmann, R. Et, and . Roblin, Gene therapy for human genetic disease?, Science, vol.175, pp.949-955, 1972.

S. L. Ginn, A. K. Amaya, I. E. Alexander, M. Edelstein, and M. R. Abedi, Gene therapy clinical trials worldwide to 2017: An update, The Journal of Gene Medicine, vol.20, p.3015, 2018.
DOI : 10.1002/jgm.3015

T. K. Guha and D. R. Edgell, Applications of Alternative Nucleases in the Age of CRISPR/Cas9, International Journal of Molecular Sciences, vol.18, 2017.

S. Hacein-bey-abina, C. Von-kalle, M. Schmidt, F. L. Deist, N. Wulffraat et al., A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency, The New England Journal of Medicine, vol.348, pp.255-256, 2003.
DOI : 10.1056/nejm200301163480314

D. H. Hamer and P. Leder, Expression of the chromosomal mouse Beta maj-globin gene cloned in SV40, Nature, vol.281, pp.35-40, 1979.

B. Hauck, L. Chen, and E. W. Xiao, Generation and characterization of chimeric recombinant AAV vectors, Molecular Therapy: The Journal of the American Society of Gene Therapy, vol.7, pp.419-425, 2003.
DOI : 10.1016/s1525-0016(03)00012-1

URL : https://doi.org/10.1016/s1525-0016(03)00012-1

W. Hayes, Recombination in Bact. coli K 12; unidirectional transfer of genetic material, Nature, vol.169, pp.118-119, 1952.

P. L. Hermonat and N. Muzyczka, Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells, Proceedings of the National Academy of Sciences of the United States of America, vol.81, pp.6466-6470, 1984.

S. J. Howe, M. R. Mansour, K. Schwarzwaelder, C. Bartholomae, M. Hubank et al., Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients, The Journal of Clinical Investigation, vol.118, pp.3143-3150, 2008.
DOI : 10.1172/jci35798

URL : http://www.jci.org/articles/view/35798/files/pdf

T. Hügle, T. Et, and . Daikeler, Stem cell transplantation for autoimmune diseases, Haematologica, vol.95, pp.185-188, 2010.

D. Ibraheem, A. Elaissari, and H. Fessi, Gene therapy and DNA delivery systems, International Journal of Pharmaceutics, vol.459, pp.70-83, 2014.
DOI : 10.1016/j.ijpharm.2013.11.041

T. E. Ichim, P. O'heeron, and E. S. Kesari, Fibroblasts as a practical alternative to mesenchymal stem cells, Journal of Translational Medicine, vol.16, p.212, 2018.
DOI : 10.1186/s12967-018-1536-1

URL : https://translational-medicine.biomedcentral.com/track/pdf/10.1186/s12967-018-1536-1

Z. Ivics, P. B. Hackett, R. H. Plasterk, and E. Z. Izsvák, Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells, Cell, vol.91, pp.501-510, 1997.

A. M. Keeler, M. K. Elmallah, and T. R. Flotte, Gene Therapy 2017: Progress and Future Directions, Clinical and Translational Science, vol.10, pp.242-248, 2017.
DOI : 10.1111/cts.12466

URL : https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12466

H. J. Kim, J. F. Greenleaf, R. R. Kinnick, J. T. Bronk, and M. E. Bolander, , 1996.

, Ultrasound-mediated transfection of mammalian cells, Human Gene Therapy, vol.7, pp.1339-1346

T. M. Klein, E. D. Wolf, R. Wu, and J. C. Sanford, High-velocity microprojectiles for delivering nucleic acids into living cells, Nature, vol.327, pp.70-73, 1987.

S. Kochanek, P. R. Clemens, K. Mitani, H. H. Chen, S. Chan et al., A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase, Proceedings of the National Academy of Sciences of the United States of America, vol.93, pp.5731-5736, 1996.

M. A. Kotterman, T. W. Chalberg, and D. V. Schaffer, Viral Vectors for Gene Therapy: Translational and Clinical Outlook, Annual Review of Biomedical Engineering, vol.17, pp.63-89, 2015.

C. S. Lee, E. S. Bishop, R. Zhang, X. Yu, E. M. Farina et al., AdenovirusMediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine, Genes & Diseases, vol.4, pp.43-63, 2017.

P. Liang, X. Zhang, Y. Chen, and J. Huang, Developmental history and application of CRISPR in human disease, The Journal of Gene Medicine, 2017.

L. Lisowski, S. S. Tay, and I. E. Alexander, Adeno-associated virus serotypes for gene therapeutics, Current Opinion in Pharmacology, vol.24, pp.59-67, 2015.

Z. Liu, Y. Wu, and E. B. Chen, Myoblast therapy: from bench to bedside, Cell Transplantation, vol.15, pp.455-462, 2006.

S. Lucas-samuel, N. Ferry, and J. Trouvin, Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products, Advances in Experimental Medicine and Biology, vol.871, pp.73-85, 2015.

D. Maeda, T. Yamaguchi, T. Ishizuka, M. Hirata, K. Takekita et al., Regulatory Frameworks for Gene and Cell Therapies in Japan, Advances in Experimental Medicine and Biology, vol.871, pp.147-162, 2015.

R. Mann, R. C. Mulligan, and D. Baltimore, Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus, Cell, vol.33, pp.153-159, 1983.

M. J. Marcaida, I. G. Muñoz, F. J. Blanco, J. Prieto, and G. Montoya, Homing endonucleases: from basics to therapeutic applications, Cellular and Molecular Life Sciences: CMLS, vol.67, pp.727-748, 2010.

D. Markowitz, S. Goff, and E. A. Bank, A safe packaging line for gene transfer: separating viral genes on two different plasmids, Journal of Virology, vol.62, pp.1120-1124, 1988.

M. V. Maus, J. A. Fraietta, B. L. Levine, M. Kalos, Y. Zhao et al., Adoptive immunotherapy for cancer or viruses, Annual Review of Immunology, vol.32, pp.189-225, 2014.

D. M. Mccarty, P. E. Monahan, and R. J. Samulski, Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis, Gene Therapy, vol.8, pp.1248-1254, 2001.

, Arzneimittelgesetz-AMG). (s. d.), Medicinal Products Act, 2018.

M. Mimeault, R. Hauke, and S. K. Batra, Stem cells: a revolution in therapeuticsrecent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies, Clinical Pharmacology and Therapeutics, vol.82, pp.252-264, 2007.

A. , Mise en application du règlement européen relatif aux essais cliniques de médicaments : bilan à 18 mois de la phase pilote-Point d'Information, Consulté, vol.15, issue.2018, 2017.

A. Mizukami and K. Swiech, Mesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization, Stem Cells International, p.4083921, 2018.

O. J. Müller, F. Kaul, M. D. Weitzman, R. Pasqualini, W. Arap et al., Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors, Nature Biotechnology, vol.21, pp.1040-1046, 2003.

C. Mussolino, T. Et, and . Cathomen, TALE nucleases: tailored genome engineering made easy, Current Opinion in Biotechnology, vol.23, pp.644-650, 2012.

L. Naldini, U. Blömer, P. Gallay, D. Ory, R. Mulligan et al., In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science, vol.272, pp.263-267, 1996.

E. Neumann, M. Schaefer-ridder, Y. Wang, and P. H. Hofschneider, Gene transfer into mouse lyoma cells by electroporation in high electric fields, The EMBO Journal, vol.1, pp.841-845, 1982.

, NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines, p.129, 2016.

S. H. Orkin and A. G. Motulsky, Report and recommendations of the panel to assess the NIH investment in research on gene therapy, vol.7, 1995.

D. ,

G. Petrof, A. Abdul-wahab, and J. A. Mcgrath, Cell therapy in dermatology. Cold Spring Harbor Perspectives in Medicine 4, 2014.

A. Phull, S. Eo, Q. Abbas, M. Ahmed, and S. J. Kim, Applications of Chondrocyte-Based Cartilage Engineering: An Overview, BioMed Research International, p.1879837, 2016.

C. Piechaczek, C. Fetzer, A. Baiker, J. Bode, and H. J. Lipps, A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells, Nucleic Acids Research, vol.27, pp.426-428, 1999.

A. M. Puumalainen, M. Vapalahti, R. S. Agrawal, M. Kossila, J. Laukkanen et al., Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses, Human Gene Therapy, vol.9, pp.1769-1774, 1998.

J. E. Rabinowitz, F. Rolling, C. Li, H. Conrath, W. Xiao et al., Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity, Journal of Virology, vol.76, pp.791-801, 2002.

, Real Decreto 223/2004, de 6 de febrero, por el que se regulan los ensayos clínicos con medicamentos. (s. d.). Noticias Jurídicas. Consulté 12 septembre, 2018.

. Règlement, du Parlement européen et du Conseil du 13 novembre 2007 concernant les médicaments de thérapie innovante et modifiant la directive 2001/83/CE ainsi que le règlement (CE), vol.726, 2004.

D. ,

. Règlement, de la Commission du 29 mars 2006 relatif à l'autorisation de mise sur le marché conditionnelle de médicaments à usage humain relevant du règlement (CE) n o 726/2004 du Parlement européen et du Conseil (Texte présentant de l, 2006.

, Cellular & Gene Therapy Products-Framework for the Regulation of Regenerative Medicine Products. WebContent. Consulté 10 septembre, 2017.

A. Ridgway, F. Agbanyo, J. Wang, and M. Rosu-myles, Regulatory Oversight of Cell and Gene Therapy Products in Canada, Advances in Experimental Medicine and Biology, vol.871, pp.49-71, 2015.

O. Ringdén, Immunotherapy by allogeneic stem cell transplantation, Advances in Cancer Research, vol.97, pp.25-60, 2007.

S. Rogers, Shope papilloma virus: a passenger in man and its significance to the potential control of the host genome, Nature, vol.212, pp.1220-1222, 1966.

S. Rogers, A. Lowenthal, H. G. Terheggen, and J. P. Columbo, Induction of arginase activity with the Shope papilloma virus in tissue culture cells from an argininemic patient, The Journal of Experimental Medicine, vol.137, pp.1091-1096, 1973.

S. Rogers, P. Et, and . Pfuderer, Use of viruses as carriers of added genetic information, Nature, vol.219, pp.749-751, 1968.

A. Saudemont, L. Jespers, and T. Clay, Current Status of Gene Engineering Cell Therapeutics, Frontiers in Immunology, vol.9, p.153, 2018.

M. Saxena, S. Balan, V. Roudko, and N. Bhardwaj, Towards superior dendritic-cell vaccines for cancer therapy, Nature Biomedical Engineering, vol.2, pp.341-346, 2018.

Y. Shi, H. Inoue, J. C. Wu, and E. S. Yamanaka, Induced pluripotent stem cell technology: a decade of progress, Nature Reviews. Drug Discovery, vol.16, pp.115-130, 2017.

H. Shihadeh, History and Recent Advances of Stem Cell Biology and the Implications for Human Health, 2015.

N. Somia, I. M. Et, and . Verma, Gene therapy: trials and tribulations, Nature Reviews. Genetics, vol.1, pp.91-99, 2000.
DOI : 10.1038/35038533

C. Song, Y. Zhang, H. Wu, X. Cao, C. Guo et al., Stem cells: a promising candidate to treat neurological disorders, Neural Regeneration Research, vol.13, pp.1294-1304, 2018.

T. Squillaro, G. Peluso, and E. U. Galderisi, Clinical Trials With Mesenchymal Stem Cells: An Update, Cell Transplantation, vol.25, pp.829-848, 2016.
DOI : 10.3727/096368915x689622

M. D. Stachler and J. S. Bartlett, Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells, Gene Therapy, vol.13, pp.926-931, 2006.

S. G. Stolberg, The biotech death of Jesse Gelsinger. The New York Times Magazine 136-140, pp.149-150, 1999.

T. Suda, D. Et, and . Liu, Hydrodynamic gene delivery: its principles and applications, Molecular Therapy: The Journal of the American Society of Gene Therapy, vol.15, pp.2063-2069, 2007.
DOI : 10.1038/sj.mt.6300314

URL : https://doi.org/10.1038/sj.mt.6300314

T. Suda, D. Et, and . Liu, Hydrodynamic delivery, Advances in Genetics, vol.89, pp.89-111, 2015.

M. Sun, Cline loses two NIH grants, Science, vol.214, p.1220, 1981.
DOI : 10.1126/science.7302590

I. M. Svane and E. M. Verdegaal, Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?, Cancer Immunology, Immunotherapy: CII, vol.63, pp.1081-1091, 2014.

J. F. Swart, E. M. Delemarre, F. Van-wijk, J. Boelens, J. Kuball et al., Haematopoietic stem cell transplantation for autoimmune diseases, Nature Reviews. Rheumatology, vol.13, pp.244-256, 2017.
DOI : 10.1038/nrrheum.2017.7

E. H. Szybalska and W. Szybalski, Genetics of human cess line. IV. DNA-mediated heritable transformation of a biochemical trait, Proceedings of the National Academy of Sciences of the United States of America, vol.48, pp.2026-2034, 1962.

K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, vol.131, pp.861-872, 2007.

Y. Takahashi, M. Nishikawa, and Y. Takakura, Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector, Frontiers in Bioscience, vol.4, pp.133-141, 2012.

M. Tanaka, H. Borgeld, J. Zhang, S. Muramatsu, J. Gong et al., Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria, Journal of Biomedical Science, vol.9, pp.534-541, 2002.

E. Tenti, G. Simonetti, M. T. Bochicchio, and G. Martinelli, Main changes in European, Contemporary Clinical Trials Communications, vol.11, issue.536, pp.99-101, 2014.

T. Horst, B. , G. Chouhan, N. S. Moiemen, and L. M. Grover, Advances in keratinocyte delivery in burn wound care, Advanced Drug Delivery Reviews, vol.123, pp.18-32, 2018.

H. G. Terheggen, A. Lowenthal, F. Lavinha, J. P. Colombo, and E. S. Rogers, Unsuccessful trial of gene replacement in arginase deficiency, Zeitschrift Fur Kinderheilkunde, vol.119, pp.1-3, 1975.

, Consulté 12 septembre, The Medicines for Human Use, 2004.

J. Tipanee, Y. C. Chai, T. Vandendriessche, and M. K. Chuah, Preclinical and clinical advances in transposon-based gene therapy, Bioscience Reports, vol.37, 2017.
DOI : 10.1042/bsr20160614

URL : http://www.bioscirep.org/content/ppbioscirep/37/6/BSR20160614.full.pdf

F. D. Urnov, E. J. Rebar, M. C. Holmes, H. S. Zhang, and P. D. Gregory, Genome editing with engineered zinc finger nucleases, Nature Reviews. Genetics, vol.11, pp.636-646, 2010.

N. Wade, UCLA gene therapy racked by friendly fire, Science, vol.210, pp.509-511, 1980.

G. Weber, U. Gerdemann, I. Caruana, B. Savoldo, N. F. Hensel et al., Generation of multi-leukemia antigen-specific T cells to enhance the graftversus-leukemia effect after allogeneic stem cell transplant, Leukemia, vol.27, pp.1538-1547, 2013.

V. M. White, H. Bibby, M. Green, A. Anazodo, W. Nicholls et al., Inconsistencies and time delays in site-specific research approvals hinder collaborative clinical research in Australia, Internal Medicine Journal, vol.46, pp.1023-1029, 2016.

T. Wicker, F. Sabot, A. Hua-van, J. L. Bennetzen, P. Capy et al., A unified classification system for eukaryotic transposable elements, Nature Reviews. Genetics, vol.8, pp.973-982, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00169819

P. Yeh, M. Et, and . Perricaudet, Advances in adenoviral vectors: from genetic engineering to their biology, FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, vol.11, pp.615-623, 1997.

Y. Yi, M. J. Noh, and K. H. Lee, Current advances in retroviral gene therapy, Current Gene Therapy, vol.11, pp.218-228, 2011.

S. F. Yu, T. Von-rüden, P. W. Kantoff, C. Garber, M. Seiberg et al., Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells, Proceedings of the National Academy of Sciences of the United States of America, vol.83, pp.3194-3198, 1986.

X. Zhang, L. Y. Tee, X. Wang, Q. Huang, and S. Yang, Off-target Effects in CRISPR/Cas9-mediated Genome Engineering, Molecular Therapy. Nucleic Acids, vol.4, p.264, 2015.

N. D. Zinder and J. Lederberg, Genetic exchange in Salmonella, Journal of Bacteriology, vol.64, pp.679-699, 1952.